Professor of Dermatology, Case West Res University
Dermatology
Dr. Neil J. Korman, MD
|
|
Give Review
Dr. Neil J. Korman is an expert in the field of Dermatology. He studied medicine at Case Western Reserve University School of Medicine. He has 9 awards "Regional Top Doctor", "Best doctor", "Teacher of the Year, Dept. of Dermatology", "Career Development Award", "Stuart Blaine Fisher, M.D. Award in Dermatology", "National Research Service Award", "Outstanding Student Award", "Tau Beta Pi (Engineering Honor Society)" and "Fellow (FAAD)". Neil Korman is also published. He has 43 publications published. The lastest publication: "Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience.' Neil J. Korman accepts Medicare.
Publications
- Translating Psoriasis guidelines into practice: Important gaps revealed.
- Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous Pemphigoid: a clinical experience.
- Definitions and outcome measures for mucous membrane Pemphigoid: Recommendations of an international panel of experts.
- Does treatment of Psoriasis reduce the risk of cardiovascular disease?
- Research gaps in Psoriasis: Opportunities for future studies.
- Relationship between metabolic syndrome and carotid intima media thickness: Cross-sectional comparison between Psoriasis and psoriatic arthritis.
- Clinical Manifestations of Pediatric Psoriasis: Results of a Multicenter Study in the United States.
- Consensus guidelines for the management of plaque Psoriasis.
- Physical and Mental Impact of Psoriasis Severity as Measured by the Compact Short Form-12 Health Survey (SF-12) Quality of Life Tool.
- Alefacept therapy for nephrogenic systemic fibrosis: a case series.
- In response to "Treatment of Psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?".
- Guidelines of care for the management of Psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of Psoriasis and psoriatic arthritis: Case-b...
- A case of multiple Skin cancers in a patient on combination immunosuppressive therapy for Behcet's disease.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of Psoriasis with phototherapy and photoche...
- Reliability and convergent validity of two outcome instruments for Pemphigus.
- A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of Psoriasis with traditiona...
- Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.
- Treatment of severe scalp Psoriasis: from the Medical Board of the National Psoriasis Foundation.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of Psoriasis with topical th...
- Treatment of intertriginous Psoriasis: from the Medical Board of the National Psoriasis Foundation.
- Mortality of bullous Pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States.
- Alefacept in the treatment of Psoriasis.
- Alefacept for moderate to severe Atopic dermatitis: a pilot study in adults.
- Consensus statement on definitions of disease, end points, and therapeutic response for Pemphigus.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an empha...
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 1. Overview of Psoriasis and guidelines of care for the treatment of Psoriasis with...
- Subcutaneous efalizumab is not effective in the treatment of alopecia areata.
- From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for Psoriasis.
- A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of Atopic dermatitis.
- Combination immunosuppressive therapies: the promise and the peril.
- Cinacalcet for the treatment of calciphylaxis.
- Cutaneous sarcoidosis successfully treated with alefacept.
- The cutting edge. Severe Hidradenitis suppurativa treated with adalimumab.
- Alefacept for the treatment of Psoriasis: a review of the current literature and practical suggestions for everyday clinical use.
- UVA and NF-kappaB activity: ironing out the details.
- Bullous Pemphigoid: what is the prognosis?
- The safety and efficacy of tacrolimus therapy in patients younger than 2 years with Atopic dermatitis.
- A nonfatal case and 2 fatal cases of paraneoplastic Pemphigus: can a complement indirect immunofluorescent test help to identify fatal "group A" paraneoplast...
- Oral and topical corticosteroids in bullous Pemphigoid.
- The first international consensus on mucous membrane Pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.
- Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in Skin lesi...
Schools
Case Western Reserve University School of Medicine
University Hosps Cleveland
NihNci
Procedures Preformed
- Destruction of Benign Skin Lesion
- Skin Tag Removal
Conditions Treated
- Actinic Keratosis
- Atopic Dermatitis (Eczema)
- Benign Skin Lesion
- Cellulitis
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Regional Top Doctor
- Best doctor
- Teacher of the Year, Dept. of Dermatology
- Career Development Award
- Stuart Blaine Fisher, M.D. Award in Dermatology
- National Research Service Award
- Outstanding Student Award
- Tau Beta Pi (Engineering Honor Society)
- Fellow (FAAD)
Education
-
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1326067778 | |
| NPPES Provider LastName | KORMAN | |
| NPPES Provider FirstName | NEIL | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Dermatology | |
| Total Claim Count | 2450.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 0.45 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326067778 |
| Last Name Of The Provider | KORMAN |
| First Name Of The Provider | NEIL |
| View All |
Similar Doctors
|
Dr. Carol C. Slover, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard E. Ranchoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Dong-Kondas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa P. Piliang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip L. Bailin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine C. Disano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodion Palazij, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael K. Schowalter, MD |
|
|
Dr. Eric C. Wilkerson, MD |